Send to

Choose Destination
Int J Lab Hematol. 2017 Dec;39(6):577-584. doi: 10.1111/ijlh.12700. Epub 2017 Jun 18.

A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.

Author information

Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Department of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Department of Hematology, Jósa András County Hospital, Nyíregyháza, Hungary.



We created a simple and effective flow cytometry scoring system (FCSS) for suspected Myelodysplastic syndromes (MDS) samples and evaluated its diagnostic and prognostic potential.


Besides evaluating the four parameters suggested by Ogata, we investigated erythroid precursors and mast cells. We evaluated the six-parameter FCSS in a four-color setting (test cohort: 51 patients; 25 controls), then we implemented it into an eight-color setting and tested it on a validation cohort of patients with MDS (n=31).


When we compared MDS cases to non-MDS samples in the test cohort, we detected significant differences regarding not only the four major parameters but also two additional ones, namely CD71 rCV% of erythroid precursors (P=.004) and mast cell percentage (MC%) (P=.001). The utilization of the modified six-parameter FCSS provided high sensitivity and specificity both in the four color (84% and 80%, respectively) and in the eight color (81% and 100%, respectively) setting, with an excellent discriminative power between MDS and non-MDS samples. Furthermore, we found significant difference in event-free survival between the risk groups based on the modified six-parameter FCSS (P=.001).


We evaluated and validated a single-tube flow cytometric procedure for a simple six-parameter FCSS which has not only high diagnostic but also prognostic power.


Myelodysplastic syndrome; erythroid CD71; flow cytometry scoring system; mast cell; rare events

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center